# Ne oldu?
The U.S. Food and Drug Administration (FDA) announced a voluntary recall of Lipofit Extreme Fat Burner 2.0, manufactured by Ana Salazar Modela Tu Cuerpo Inc., after laboratory analysis detected undeclared fluoxetine in the daytime (AM) tablets and undeclared 2,4-Dinitrophenol (DNP) in the nighttime (PM) tablets. Both substances are not listed on the product label and pose significant health hazards.
# Şu anda bilinenler
- Fluoxetine: An FDA-approved medication used to treat depression, bulimia and obsessive‑compulsive disorder. Its presence in a weight‑loss supplement without disclosure is illegal and may cause serious adverse effects, particularly in users who are already taking antidepressants or have underlying heart conditions.
- 2,4‑Dinitrophenol (DNP): A toxic chemical that is not approved by the FDA for any use. Historically marketed as a weight‑loss aid, DNP interferes with cellular energy production and can cause dangerously high body temperature, organ failure and death.
- The product is classified as an unapproved new drug because its safety and efficacy have not been established.
- No independent verification of the FDA’s single‑lab findings has been published to date.
# Sırada ne var?
Consumers who have purchased Lipofit Extreme Fat Burner 2.0 should stop using the product immediately and contact the retailer for a refund. Ana Salazar Modela Tu Cuerpo Inc. is coordinating the nationwide recall. The FDA advises anyone experiencing adverse effects to seek medical attention and report symptoms to the agency’s MedWatch program. Further testing or follow‑up communications from the manufacturer are expected as the recall progresses.